Rewired Targets Growth-Stage AI Ventures

LONDON & LAUSANNE, Switzerland.-Tuesday 31 March 2020 [ AETOS Wire ]

Rewired is seeking to make new investments of $5m to $30m in growth-stage artificial intelligence and robotics ventures.

The deep-tech fund invests in applied science and technologies and says it is vital that investment continues despite ongoing global events.

Rewired received $100m of new funding in 2019 from investor Tej Kohli.

(BUSINESS WIRE)-- Rewired, the robotics focused venture studio that invests in growth-stage technology ventures, is seeking to add new artificial intelligence and robotics investments to its portfolio. The portfolio currently encompasses innovations in machine learning, robotics, bionics, smart sensors, mapping and localization in the UK and USA.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200330005016/en/

Backed by investors who believe that analysts are underestimating the prospects of AI, Rewired seeks to make investments of between $5m and $30m. Its status as a venture studio means that Rewired uniquely seeks to attain a substantial or majority position as an investor, and to then provide long term funding and expertise. The Rewired approach is to alleviate founders from the burden of constant fundraising so they can focus on growth, whilst avoiding the dilution that VC’s typically accept during multiple funding rounds.

Rewired is seeking to back ventures that require growth capital to scale existing proprietary solutions that have already been proven, with a clear pathway to profitable growth. Experienced founders and a management team with commercial credibility in the intended marketplace are also a prerequisite for a Rewired investment, as is acceptance that the venture studio seeks to take a significant equity stake and to play a very active role.

Rewired has also made two new appointments in its Swiss office to support future deal flow. Laurent Bischof has joined Rewired as a Board Director. In 2016 Laurent co-founded Bloom, the first AI platform dedicated to strategic analysis of social networks. He also has over 15 years of venture capital experience. Marc-Olivier Bertholet has joined Rewired as a special advisor with over 20 years of international biotech and MedTech experience.

Many of the ventures backed by Rewired have humanitarian applications. In October 2017 Rewired led the funding round for Mountain View-based Aromyx, a venture that has developed olfactory biosensors that enable machines to taste and smell. In 2019 Aromyx completed successful trials of its olfactory sensor technology with a global plastics and chemicals company. Less than 10% of the world’s plastics are currently being recycled, with odour quality being a major barrier to broad-scale recycling. The 2019 trials indicated that the Aromyx technology could help to raise global plastic recycling to between 60% and 80%.

In 2017 Rewired also backed Bristol-based Open Bionics, a robotics manufacturer that has developed the next generation of 3D-printed bionic limbs. The company’s ‘Hero Arm’ is the world’s first clinically approved 3D-printed bionic arm. Since its fundraising, Open Bionics has expanded and exported bionic arms to the USA, Europe Australia and New Zealand.

Based in London in the United Kingdom and Lausanne in Switzerland, Rewired is funded by investors including the Cascade Global multi-family office and the Kohli Ventures investment vehicle of Tej Kohli. Cascade Global is also an investor in the Rewired.GG sister fund, which in 2019 became Europe largest esports investor when it invested €34m in an esports team.

Laurent Bischof, newly appointed Board Director of Rewired said:

“The majority of Rewired investments are still in stealth mode. But we believe that artificial intelligence and robotics will change everything, from making businesses more efficient to improving healthcare and even extending human life. The ventures that Rewired seeks to back are building the technology platforms that will help to power the new economy.”

Amit Jain, CEO of Cascade Global said:

“There are unprecedented events in the world at the moment and it is vital that we continue to invest in building the future through funds like Rewired. The promise of the artificial intelligence economy offers unprecedented opportunities to improve every aspect of human life and Rewired seeks to back the ventures that will enable this future.”

Tej Kohli, investor in Rewired said:

“I believe that artificial intelligence will change the world for the better and will be the biggest thing to ever happen to humanity. I am fascinated by the technologies that will be needed in order to put artificial intelligence into everything. This is exactly where I have placed my investment focus and Rewired aligns with this investment outlook entirely.”

Josh Silverman, CEO of Aromyx said:

“Since Rewired recapitalised with $100m of new funding in 2019, the team has always been emphatic that they have the resources available for $20m+ of further funding that could be made available to us. This is commensurate with what I have come to learn is the Rewired philosophy - that founders are free to build their company without constant fund-raisings.”

About Rewired

Rewired is a robotics focused venture studio and investment fund. Established in 2017 in the United Kingdom and Switzerland, the Rewired thesis is that artificial intelligence can make every industry and everything that is around us perform better with minimal human input. Rewired is on a mission to master the constellation of technologies that will enable this AI economy. This involves looking past the capabilities of human perception and into new technologies that allow us to tap into and create entirely new modalities of data and advancements that will enable the optimal application of AI throughout everyday life.

Click here to watch a video about Rewired

Click here to visit the Rewired website

View source version on businesswire.com: https://www.businesswire.com/news/home/20200330005016/en/

Contacts

Media Contacts
Michael Macfarlane
mike@rewired.com


Permalink : https://www.aetoswire.com/news/rewired-targets-growth-stage-ai-ventures/en

Diligent Offers Seamless Video Conferencing Access Across All Board Management Platforms to Ensure Secure, Virtual Board Meetings as the Workforce Shifts Remote

New functionality in Diligent Boards, BoardEffect, and Community by Diligent mitigates security risks associated with virtual meetings by offering one-click access to video conferencing solutions

NEW YORK-Tuesday 31 March 2020 [ AETOS Wire ]

(BUSINESS WIRE)-- Diligent announced today a new, more secure approach to video conferencing across its board management applications – including Diligent Boards for enterprise, BoardEffect for nonprofits, and Community by Diligent for schools and local government – as board meetings and sensitive leadership discussions shift to a remote setting due to the COVID-19 pandemic and in preparation for the future of work.

Directors and executives can join confidential virtual meetings with one click from within Diligent’s suite of secure board applications – mitigating the risk associated with sharing meeting invite links to unsecure devices on home networks and personal email accounts that can easily be intercepted. Access to links to virtual meetings within Diligent’s platforms includes leading video applications like Zoom, WebEx, and Go-To-Meeting.

This update comes as organizations increase the frequency of confidential board and committee meetings to manage the COVID-19 crisis, in addition to preparing for long-scheduled quarterly board meetings and annual shareholder meetings. As video conferences become an increasingly important collaboration tool across the organization, corporations will require advanced security protocols to protect sensitive, confidential meeting information from leakage or attack.

Diligent has built its suite of leading modern governance applications with these security challenges in mind and is preparing board directors and company executives for a future of work that is much more virtual. In addition to improving the user experience, the enhanced video conference functionality removes the liability of distributing meeting invite links in shared calendars across devices and on unsophisticated personal networks.

“Modern governance is crucial during these unprecedented times. The sudden shift to remote meetings is a major adjustment but also preparing us for the future of work, where executives and boards will require better, more private and secure, mobile tools.” said Brian Stafford, CEO of Diligent. “Diligent is committed to innovating to support our clients. Board members already have the routine of going into our application for all their materials. With the shift to virtual meetings, we are centralizing the meetings on Diligent, making it easier for directors to join the video conference and helping companies securely distribute meeting information.”

Diligent’s functionality to support virtual meetings is built within its board management applications – Boards, BoardEffect and Community – and can help organizations large and small collaborate, communicate, and manage crises remotely and securely, which is imperative to driving modern governance during the ongoing response to COVID-19. To learn more about moving meetings virtual, visit: https://insights.diligent.com/crisis-management/virtual-meetings-how-to-get-your-board-up-running.

About Diligent

Diligent is leading the way in modern governance. Diligent empowers leaders to turn governance into a competitive advantage through unparalleled insight and highly secure, integrated SaaS applications, helping organizations thrive and endure in today’s complex, global landscape. The company’s trusted, cloud-based applications streamline the day-to-day work of board management and committees, support collaboration and secure information sharing throughout the organization, manage subsidiary and entity data, and deliver the insights and information leaders need to mitigate governance deficits and seize new opportunities.

The largest global network of corporate directors and executives, Diligent is relied on by more than 17,000 organizations and 650,000 leaders in over 90 countries. With award-winning customer service across the globe, Diligent serves more than 50% of the Fortune 1000, 70% of the FTSE 100, and 65% of the ASX. Diligent also operates the largest global platform for nonprofits boards in BoardEffect and a leading platform for school boards with Community by Diligent.

Visit www.diligent.com to learn how modern governance helps organizations outperform and turn governance into a strategic advantage.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200327005276/en/

Contacts

Nicholas Koulermos
Diligent@5wpr.com
646-843-1812



Permalink : https://www.aetoswire.com/news/diligent-offers-seamless-video-conferencing-access-across-all-board-management-platforms-to-ensure-secure-virtual-board-meetings-as-the-workforce-shifts-remote/en

Multi-Lingual Support From the Global MediXchange of Combating COVID-19 (GMCC) Programme to Further Enable Sharing Among Medical Personnel Worldwide

HANGZHOU, China-Thursday 26 March 2020 [ AETOS Wire ]

(BUSINESS WIRE)-- Over 440 medical institutions from 104 countries and regions have applied to learn and share experiences in battling COVID-19 through the International Medical Expert Communication Platform. The Handbook of COVID-19 Prevention and Treatment is now available in seven languages with more to come.

The platform, a centerpiece of the Global MediXchange for Combating COVID-19 (GMCC) program, was jointly established by the Jack Ma Foundation and Alibaba Foundation. It is designed for medical experts around the world to communicate seamlessly with each other to share their invaluable experience of fighting coronavirus disease 2019 (COVID-19) and to ask and answer each other’s questions. To date, the most applications have come in thus far from medical institutions in the U.S, Turkey, the U.K., Pakistan, Spain and Germany.

Medical staff need to apply and be approved to join the platform. Once they’re accepted, they’re free to participate in individual or group discussions and sessions.

“Knowledge is power! We launched an online platform for doctors and nurses around the world to exchange ideas, lessons and know-how to fight the virus. We welcome all hospitals to join Chinese hospitals on this open platform https://covid-19.alibabacloud.com. One world, one fight!" Jack Ma wrote in a tweet Wednesday.

Tapping Alibaba Group’s DingTalk messaging and communications functions, the digital platform provides free audio and video conference functionality, along with live broadcast functions for more-complex scenarios. Medical workers from different countries can choose to communicate with their fellow doctors individually, or they can participate in live-sharing group sessions to interact with multiple participants, using real-time artificial intelligence translation to overcome communication barriers. The First Affiliated Hospital, Zhejiang University School of Medicine (FAHZU), for example, has been using the platform to share their valuable experience with 92 medical institutions from 44 countries and regions.

A playback function allows further sharing or posting on official websites for consumption anytime – and for those who can’t join the live broadcasts due to the time difference or if they are occupied by their duties.

To date, the International Medical Expert Communication Platform has attracted numerous Chinese medical institutions, including Zhongnan Hospital of Wuhan University (Wuhan Leishenshan Hospital), The First Affiliated Hospital, Zhejiang University School of Medicine (FAHZU), and others.

Through video conferencing and AI translation from and into 11 languages (Arabic, Chinese, English, French, Indonesian, Japanese, Russian, Spanish, Thai, Turkish, and Vietnamese), the platform aims to build a virtual community.

DingTalk, which powers this platform, has also been tabbed by UNESCO as facilitating distance learning during the coronavirus outbreak.

Also as part of the GMCC programme, the Handbook of COVID-19 Prevention and Treatment, authored by The First Affiliated Hospital, Zhejiang University School of Medicine and compiled according to clinical experience, is now available at no cost in Chinese, English, French, Italian, Japanese, Turkish and Spanish. This handbook provides comprehensive guidelines and best practices by China's top experts for coping with COVID-19. More languages will be added soon, as the GMCC programme continues to launch more anti-epidemic resources and provide more practical suggestions and references for medical staff worldwide.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200325005799/en/

Contacts

Luica Mak
+44-7905471332
luica.mak@alibaba-inc.com

Crystal Liu
+86 18578497650
Crystal.liu@alibaba-inc.com

Permalink : https://www.aetoswire.com/news/multi-lingual-support-from-the-global-medixchange-of-combating-covid-19-gmcc-programme-to-further-enable-sharing-among-medical-personnel-worldwide/en

TruDoc 24x7 DHA licensed doctors provide convenient and round-the-clock teleconsultations to help ease panic surrounding COVID-19

Dubai, United Arab Emirates, -Monday 30 March 2020 [ AETOS Wire ]

TruDoc Healthcare has risen to the occasion in the wake of the COVID-19 outbreak and has been providing patients with appropriate medical management and advice quickly and conveniently given the present medical situation. It is already experiencing an upsurge in audio and video consultations related to respiratory tract infections and other similar illnesses. TruDoc 24x7 is at the forefront of helping people stay informed with the latest information on the COVID-19, warning signs and symptoms and preventive measures to combat this pandemic.

Any individual can call in and speak to a doctor from the convenience of their home or office, anytime and anywhere in the world to check for their health queries. If they are concerned about any symptoms related to COVID-19 or looking for comprehensive information on the illness, typical symptoms and precautions to be followed, they can video or audio call and get truthful and unbiased medical diagnoses from highly trained, DHA licensed doctors rather than relying on unreliable information.

As per Dubai Health Authority guidelines, given the current scenario, it is best to avoid close contact with people and public assemblies and congregations, among other preventive measures. Also, If any person has recently travelled to any country or city which has reported COVID-19 cases or been in contact with someone who has made such travel, and has been experiencing any of the symptoms like fever, cough and difficulty in breathing, it is highly advised that he/she seek medical attention.

TruDoc 24x7 upholds the regulatory bodies’ mandate and urges patients to avoid overcrowded hospitals and facilities and rather, utilize immediate video consultations with doctors from the comfort of their home or workplace and save themselves from unnecessary trips to the hospital and thereby, hospital acquired infections. Our experienced physicians who are highly trained and DHA licensed on telehealth practices are also able to request lab tests as well as issue electronic prescriptions for acute and chronic conditions and ensure delivery of medications, wherever applicable.

Dr. Ebtihal Darwish, our Chief Medical Officer; Dr. Veena Pillai, our Senior Medical Director and Dr. Yosef Alsaieq, our COVID-19 Medical Director are all strong advocate of 24x7 access to doctors in today’s digital age as they find this as the need of the hour. Our full-time team of licensed doctors, wellness advisors and case managers are available 24x7 to support people during the coronavirus pandemic. As the leading telemedicine provider in the UAE for the past 8 years and with 3.4 million paid subscribers, we ensure that we continue “Doing the Right Thing”. Our doctors tell patients the truth about what they need, not what they can afford.

TruDoc 24x7 brings the perfect blend of technology and medical expertise to its members by providing a one-of-a-kind 24x7 Population Health Management solution for individuals with acute and chronic conditions and people who need to achieve a healthier lifestyle.

Contacts

SAHARA Communications

Noor Abdelhafez, Account Executive, +97143298996, +971506946519

n.hafiz@saharapr.com / www.saharagcc.com  


Permalink : https://www.aetoswire.com/news/trudoc-24x7-dha-licensed-doctors-provide-convenient-and-round-the-clock-teleconsultations-to-help-ease-panic-surrounding-covid-19/en

C3.ai, Microsoft, and Leading Universities Launch C3.ai Digital Transformation Institute

 C3.ai, Microsoft Corporation, the University of Illinois at Urbana-Champaign; the University of California, Berkeley; Princeton University; the University of Chicago; the Massachusetts Institute of Technology; and Carnegie Mellon University form the new C3.ai Digital Transformation Institute

First call for proposals published – AI Techniques to Mitigate Pandemic

Institute to accelerate AI innovation among scientific communities to bring greater advocacy, invention, collaboration, and academic rigor to scaling digital transformation

REDWOOD CITY, Calif. & REDMOND, Wash. & URBANA-CHAMPAIGN, Ill. & BERKELEY, Calif.-Monday 30 March 2020 [ AETOS Wire ]

(BUSINESS WIRE)-- C3.ai, Microsoft Corporation, the University of Illinois at Urbana-Champaign (UIUC), the University of California, Berkeley, Princeton University, the University of Chicago, the Massachusetts Institute of Technology, Carnegie Mellon University, and the National Center for Supercomputing Applications at UIUC announced two major initiatives:

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200326005334/en/

    C3.ai Digital Transformation Institute (C3.ai DTI), a research consortium dedicated to accelerating the application of artificial intelligence to speed the pace of digital transformation in business, government, and society. Jointly managed by UC Berkeley and UIUC, C3.ai DTI will sponsor and fund world-leading scientists in a coordinated effort to advance the digital transformation of business, government, and society.
    C3.ai DTI First Call for Research Proposals: C3.ai DTI invites scholars, developers, and researchers to embrace the challenge of abating COVID-19 and advance the knowledge, science, and technologies for mitigating future pandemics using AI. This is the first in what will be a series of bi-annual calls for Digital Transformation research proposals.

“The C3.ai Digital Transformation Institute is a consortium of leading scientists, researchers, innovators, and executives from academia and industry, joining forces to accelerate the social and economic benefits of digital transformation,” said Thomas M. Siebel, CEO of C3.ai. “We have the opportunity through public-private partnership to change the course of a global pandemic,” Siebel continued. “I cannot imagine a more important use of AI.”

Immediate Call for Proposals: AI Techniques to Mitigate Pandemic

Topics for Research Awards may include but are not limited to the following:

    Applying machine learning and other AI methods to mitigate the spread of the COVID-19 pandemic
    Genome-specific COVID-19 medical protocols, including precision medicine of host responses
    Biomedical informatics methods for drug design and repurposing
    Design and sharing of clinical trials for collecting data on medications, therapies, and interventions
    Modeling, simulation, and prediction for understanding COVID-19 propagation and efficacy of interventions
    Logistics and optimization analysis for design of public health strategies and interventions
    Rigorous approaches to designing sampling and testing strategies
    Data analytics for COVID-19 research harnessing private and sensitive data
    Improving societal resilience in response to the spread of the COVID-19 pandemic
    Broader efforts in biomedicine, infectious disease modeling, response logistics and optimization, public health efforts, tools, and methodologies around the containment of rising infectious diseases and response to pandemics, so as to be better prepared for future infectious diseases

The first call for proposals is open now, with a deadline of May 1, 2020. Researchers are invited to learn more about C3.ai DTI and how to submit their proposals for consideration at C3DTI.ai. Selected proposals will be announced by June 1, 2020.

Up to $5.8 million in awards will be funded from this first call, ranging from $100,000 to $500,000 each. In addition to cash awards, C3.ai DTI recipients will be provided with significant cloud computing, supercomputing, data access, and AI software resources and technical support provided by Microsoft and C3.ai. This will include unlimited use of the C3 AI Suite and access to the Microsoft Azure cloud platform and access to the Blue Waters supercomputer at the National Center for Supercomputing Applications (NCSA) at UIUC.

“We are collecting a massive amount of data about MERS, SARS, and now COVID-19,” said Condoleezza Rice, former US Secretary of State. “We have a unique opportunity before us to apply the new sciences of AI and digital transformation to learn from these data how we can better manage these phenomena and avert the worst outcomes for humanity,” Rice continued. “I can think of no work more important and no response more cogent and timely than this important public-private partnership.”

“We’re excited about the C3.ai Digital Transformation Institute and are happy to join on a shared mission to accelerate research at these eminent research institutions,” said Eric Horvitz, Chief Scientist at Microsoft and C3.ai DTI Advisory Board Member. “As we launch this exciting private-public partnership, we’re enthusiastic about aiming the broader goals of the Institute at urgent challenges with the COVID-19 pandemic, as well as on longer-term research that could help to minimize future pandemics.”

"At UC Berkeley, we are thrilled to help co-lead this important endeavor to establish and advance the science of digital transformation at the nexus of machine learning, IoT, and cloud computing,” said Carol Christ, Chancellor, UC Berkeley. “We believe this Institute has the potential to make tremendous contributions by including ethics, new business models, and public policy to the technologies for transforming societal scale systems globally."

“The C3.ai Digital Transformation Institute, with its vision of cross-institutional and multi-disciplinary collaboration, represents an exciting model to help accelerate innovation in this important new field of study,” said Robert J. Jones, Chancellor of the University of Illinois at Urbana-Champaign. “At this time of a global health crisis, the Institute’s initial research focus will be on applying AI to mitigate the COVID-19 pandemic and to learn from it how to protect the world from future pandemics. C3.ai DTI is an important addition to the world’s fight against this disease and a powerful new resource in developing solutions to all societal challenges.”

“Together with the other C3.ai Digital Transformation Institute partners, we look forward to creating a powerful ecosystem of scholars and educators committed to applying 21st century technologies to the benefit of all,” said Chris Eisgruber, President of Princeton University. “This public-private partnership with innovators like C3.ai and Microsoft, providing support to world-class researchers across a range of disciplines, promises to bring rapid innovation to an exciting new frontier.”

“By strongly supporting multidisciplinary research and multi-institution projects, the C3.ai DTI represents a new avenue to develop breakthrough scientific results with a positive impact on society at a time of great need,” said Robert Zimmer, President of the University of Chicago. “I’m very pleased that the University of Chicago is part of this formidable collaboration between academia and industry to lead crucial innovation with great purpose and urgency.”

“The vision of C3.ai DTI is driven by the recognition of digital transformation as both a science as well as a scientific imperative for this pivotal time, applicable to every sector of our economy across the public and private sectors, including in healthcare, education, and public health,” said Farnam Jahanian, President of Carnegie Mellon University. “We are excited to participate in building out the Institute’s structure, program and further alliances. This is just the beginning of an ambitious journey that can have enormous positive impact on the world.”

"At MIT, we share the commitment of C3.ai DTI to advancing the frontiers of AI, cybersecurity and related fields while building into every inquiry a deep concern for ethics, privacy, equity and the public interest,” said Rafael Reif, President of the Massachusetts Institute of Technology. “At this moment of national emergency, we are proud to be part of this intensive effort to apply these sophisticated tools to better analyze the COVID-19 epidemic and devise effective ways to stop it. We look forward to accelerating this work both by collaborating with the companies and institutions in the initiative, and by drawing on the frontline experience and clinical data of our colleagues in Boston's world-class hospitals."

Building Community

At the heart of C3.ai DTI will be the constant flow of new ideas and expertise provided by ongoing research, visiting professors and research scholars, and faculty and scholars in residence, many of whom will come from beyond the member institutions. This rich ecosystem will form the foundational structure of a new Science of Digital Transformation.

“This is about global innovation based on multinational collaboration to accelerate the positive impact of AI by providing researchers access to real world data and to massive resources,” said Jim Snabe, Chairman, Siemens. “This is exactly the kind of multinational public-private partnership that is required to address this critical issue.”

“I could not be more proud of our association with C3.ai and Microsoft,” said Lorenzo Simonelli, CEO of Baker Hughes. “This is exactly the kind of leadership that is required to bring together the best of us to address this critical need.”

“We are at war and we must win it! Using all means,” said Jacques Attali, French statesman. “This great project will organize global scientific collaboration for accelerating the social impact of AI, and help to win this war, using new weapons, for the best of mankind.”

“In these difficult times, we need – now more than ever – to join our forces with scholars, innovators, and industry experts to propose solutions to complex problems. I am convinced that digital, data science and AI are a key answer,” said Gwenaëlle Avice-Huet, Executive Vice President of ENGIE. “The C3.ai Digital Transformation Institute is a perfect example of what we can do together to make the world better.”

Establishing the New Science of Digital Transformation

C3.ai DTI will focus its research on AI, Machine Learning, IoT, Big Data Analytics, human factors, organizational behavior, ethics, and public policy. The Institute will support the development of ML algorithms, data security, and cybersecurity techniques. C3.ai DTI research will analyze new business operation models, develop methods of implementing organizational change management and protecting privacy, and amplify the dialogue around the ethics and public policy of AI.

C3.ai Digital Transformation Institute is a Research Initiative that Includes:

    Research Awards: Up to 26 cash awards annually, ranging from $100,000 to $500,000 each
    Computing Resources: Access to free Azure Cloud and C3 AI Suite resources
    Visiting Professors & Research Scientists: $750,000 per year to support C3.ai DTI Visiting Scholars
    Curriculum Development: Annual awards to faculty at member institutions to develop curricula that teach the emerging field of Digital Transformation Science
    Data Analytics Platform: C3.ai DTI will host an elastic cloud, big data, development, and operating platform, including the C3 AI Suite hosted on Microsoft Azure for the purpose of supporting C3.ai DTI research, curriculum development, and teaching.
    Educational Program: $750,000 a year to support an annual conference, annual report, newsletters, published research, and website
    Industry Alignment: C3.ai DTI Industry Partners will be established to assure the institute’s operations are aligned to the needs of the private sector.
    Open Source: C3.ai DTI will strongly favor proposals that promise to publish their research in the public domain.

To support the Institute, C3.ai will provide C3.ai DTI $57,250,000 in cash contributions over the first five years of operation. C3.ai and Microsoft will contribute an additional $310 million in-kind, including use of the C3 AI Suite and Microsoft Azure computing, storage, and technical resources to support C3.ai DTI research.

To learn more about C3.ai DTI’s program, award opportunities, and call for proposals, please visit C3DTI.ai.

About C3.ai Digital Transformation Institute

C3.ai Digital Transformation Institute represents an innovative vision to take AI, ML, IoT, and big data research in a consortium model to a level that cannot be achieved at any one institution alone. Jointly managed and hosted by the University of California, Berkeley and the University of Illinois at Urbana-Champaign, C3.ai DTI will attract the world’s leading scientists to join in a coordinated and innovative effort to advance the digital transformation of business, government, and society, and establish the new Science of the Digital Transformation of Societal Systems.

About C3.ai

C3.ai is a leading AI software provider for accelerating digital transformation. C3.ai delivers the C3 AI Suite for developing, deploying, and operating large-scale AI, predictive analytics, and IoT applications in addition to an increasingly broad portfolio of turn-key AI applications. The core of the C3.ai offering is a revolutionary, model-driven AI architecture that dramatically enhances data science and application development. Learn more at: www.c3.ai.

About Microsoft

Microsoft (Nasdaq “MSFT” @microsoft) enables digital transformation for the era of an intelligent cloud and an intelligent edge. Its mission is to empower every person and every organization on the planet to achieve more.

About University of Illinois at Urbana-Champaign

The University of Illinois at Urbana-Champaign is a public land-grant research university founded in 1867 and dedicated to building upon a tradition of excellence in education, research, public engagement and economic development. The university pioneers innovative research that tackles global problems and expands the human experience. Illinois faculty, staff and alumni have been leading the way in digital transformation from the invention of the transistor to the birth of the graphical internet browser to high performance computing to the new revolution in data sciences and analytics.

About University of California, Berkeley

UC Berkeley is the world’s premier public university with a mission to excel in teaching, research and public service. This longstanding mission has led to the university's distinguished record of Nobel-level scholarship, constant innovation, a concern for the betterment of our world, and consistently high rankings of its schools and departments. The campus offers superior, high-value education for extraordinarily talented students from all walks of life, operational excellence, and a commitment to the competitiveness and prosperity of California and the nation.

About Princeton University

Princeton University is a vibrant community of teaching and research that stands in the nation's service and the service of humanity. Chartered in 1746, Princeton is the fourth-oldest college in the United States. Princeton is an independent, coeducational, nondenominational institution that provides undergraduate and graduate instruction in the arts and humanities, social sciences, natural sciences, and engineering.

About University of Chicago

The University of Chicago is a leading academic and research institution that has driven new ways of thinking since its founding in 1890. As an intellectual destination, the University draws scholars and students from around the world to its campuses and centers around the globe. The University provides a distinctive educational experience and research environment, empowering individuals to challenge conventional thinking and pursue field-defining research that produces new understanding and breakthroughs with global impact.

About Massachusetts Institute of Technology

The Massachusetts Institute of Technology is dedicated to advancing knowledge and educating students in science, technology, and other areas of scholarship that will best serve the nation and the world in the 21st century. The Institute has more than 1,000 faculty members and over 11,500 undergraduate and graduate students. MIT's commitment to innovation has led to a host of scientific breakthroughs and technological advances, in fields ranging from aeronautics to computing to cancer research.

About Carnegie Mellon University

Carnegie Mellon (cmu.edu) is a private, internationally ranked research university with programs in areas ranging from science, technology and business, to public policy, the humanities and the arts. More than 14,000 students in the university’s seven schools and colleges benefit from a small student-to-faculty ratio and an education characterized by its focus on creating and implementing solutions for real problems, interdisciplinary collaboration and innovation.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200326005334/en/

Contacts

C3.ai Contact:
April Marks
Director of Public Relations
917-574-5512
pr@c3.ai

Microsoft Contact:
Microsoft Media Relations
WE Communications for Microsoft
(425) 638-7777
rrt@we-worldwide.com

UIUC Contact:
Robin Kaler
Associate Chancellor for Public Affairs
rkaler@illinois.edu
217-333-5050

University of California, Berkeley Contact:
Sarah Yang
Assistant Dean, Marketing & Communications
Berkeley Engineering
scyang@berkeley.edu

Princeton University Contact:
Ben Chang
Deputy Vice President, Communications
mediarelations@princeton.edu

University of Chicago Contact:
Rob Mitchum
Associate Director of Communications for Data Science and Computing
rmitchum@uchicago.edu
773-484-9890

MIT Contact:
Anne Stuart
Communications Officer in Electrical Engineering and Computer Science
astuart@mit.edu

Carnegie Mellon University Contact:
Jason Maderer
Sr. Director, Media Relations
412.268.1151
maderer@cmu.edu

Permalink : https://www.aetoswire.com/news/c3ai-microsoft-and-leading-universities-launch-c3ai-digital-transformation-institute-nbsp/en

ABB: COVID-19 Update

ZURICH-Monday 30 March 2020 [ AETOS Wire ]

(BUSINESS WIRE)-- ABB is constantly monitoring the pandemic situation around COVID-19 (novel coronavirus). The health and safety of its employees, customers and partners remains the company’s number one priority and we are working hard to assess and mitigate any risks.

Guidance issued on February 5, 2020, did not include impacts due to the coronavirus, the effects of which were mainly limited to China at that time. We have subsequently experienced a decline in trading conditions due to the outbreak, further impacted by a weakening oil price.

The situation in China has stabilized following extensive government-led efforts in February and operations at ABB’s three main production hubs of Shanghai, Beijing and Xiamen have largely returned to normal. While weakened customer demand in China, our second largest market, will also impact the first quarter results, our China business has been improving recently. At the same time, COVID-19 has spread rapidly to the western hemisphere in March, resulting in governments and customers adopting containment measures that have material economic consequences across the globe.

Q1 2020 impact

Although it is not yet possible to determine the exact impact of COVID-19 on ABB’s first quarter results, ABB expects revenues to decline in all its businesses relative to a year ago, while orders are somewhat less impacted. The Robotics & Discrete Automation business, which was already facing significant end-market headwinds from the automotive sector, remains challenged, with first quarter orders and revenues both expected to decline by more than 20 percent year-on-year.

Operational EBITA margins are also expected to decline in all ABB’s businesses, burdened by lower volumes, partly offset by self-help efforts. Self-help initiatives are aided by the framework ABB already has in place to implement ABB’s Operating System (ABB-OS). At the same time, the company is significantly intensifying mitigation measures and actively reducing all non-essential costs, and all of ABB’s businesses are rigorously focused on serving their customers while sustaining cash flow.

2020 outlook

Each of our businesses are closely monitoring current and potential effects of the outbreak. Currently, the majority of ABB’s production facilities remain fully or partly operational and supply chain impacts have been minimal. However, the outbreak is expected to continue to have an impact globally, potentially creating disruption across production sites and further curtailing product demand, project and service activity.

In addition to short-cycle headwinds impacting all our businesses, we expect project business to be dampened by the weaker outlook for oil and gas capital expenditures and a fall-off in cruise ship activity. By contrast, transport projects look more resilient and the outlook for select high growth areas, such as data centers, remains robust. Systems and service activity is curtailed by restrictions to cross-border travel for specialized sales and service engineers.

ABB is accelerating and extending its mitigation measures ahead of what looks set to be a difficult second quarter, with a focus on adjusting capacity to meet reduced demand.

Given continued uncertainty, including the recent oil price decline, ABB is no longer providing financial guidance for full year 2020.

ABB continues to work toward the delivery of transformation milestones, including the divestment of Power Grids which is targeted for completion at the end of the second quarter.

Despite short-term disruptions, ABB is confident in the underlying resilience of its businesses and operating model, and that its short-term liquidity needs are well covered by the financial framework it has in place.

“I would like to take this opportunity during these extraordinary times to thank the whole ABB team for sticking together and handling this global pandemic with the highest level of professionalism,” said ABB CEO Björn Rosengren. “The health and safety of all stakeholders, above all our employees, remains our number one priority at this moment in time, while we also try our utmost to secure business continuity. We remain prepared for any scenario and will take strong action to mitigate the impact for our customers, shareholders and employees.”

“Furthermore, the Board of Directors and the Executive Committee of ABB have decided to voluntarily take an immediate 10 percent reduction in board compensation and salary for the duration of the crisis, with the view to extend this strong sign of solidarity to other senior management levels within the company. We must stay strong together for the whole of ABB and for our society. The money saved through the compensation and salary reductions will be donated by ABB towards efforts aimed at fighting the impacts of the Coronavirus crisis,” said the CEO.

“After many of my first meetings since joining ABB earlier this year, my impressions of the company and its people are very positive. ABB is a strong company, with a tremendous spirit and the right products and technology to drive the positive and sustainable development of the world in the future,” Rosengren added.

ABB plans for virtual communication

In light of the current situation around COVID-19, ABB plans to make more use of virtual media to facilitate continued communication with the financial community.

The following webcasts are currently scheduled:

Date
   


   

Topic
   


   

Host

April 28, 2020
   


   

Q1 Results: webcast
   


   

CEO, CFO

June 10, 2020
   


   

CEO first perspectives: webcast
   


   

CEO, CFO

Full details and additional events will be updated on www.abb.com/investorrelations when available.

ABB (ABBN: SIX Swiss Ex) is a technology leader that is driving the digital transformation of industries. With a history of innovation spanning more than 130 years, ABB has four, customer-focused, globally leading businesses: Electrification, Industrial Automation, Motion, and Robotics & Discrete Automation, supported by the ABB Ability™ digital platform. ABB’s Power Grids business will be divested to Hitachi in 2020. ABB operates in more than 100 countries with about 144,000 employees.

This information is information that ABB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 6.45 a.m. CEST on March 30, 2020.

Important notice about forward-looking information

This press release includes forward-looking information and statements concerning the outlook for our business. These statements are based on current expectations, estimates and projections about the factors that may affect our future performance, including the future impact of the coronavirus, global economic conditions, and the economic conditions of the regions and industries that are major markets for ABB. These expectations, estimates and projections are generally identifiable by statements containing words such as “anticipates”, “expects,” “believes,” “estimates,” “plans”, “targets” or similar expressions. However, there are numerous risks and uncertainties, many of which are beyond our control, that could cause our actual results to differ materially from the forward-looking information and statements made in this press release and which could affect our ability to achieve any or all of our stated targets. Many of the factors that could cause such differences are identified and discussed from time to time in ABB Ltd’s filings with the U.S. Securities and Exchange Commission, including its Annual Reports on Form 20-F. Although ABB Ltd believes that its expectations reflected in any such forward-looking statement are based upon reasonable assumptions, it can give no assurance that those expectations will be achieved.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200329005041/en/

Contacts

ABB Ltd
Affolternstrasse 44
8050 Zurich
Switzerland

Media Relations
Phone: +41 43 317 71 11
Email: media.relations@ch.abb.com

Investor Relations
Phone: +41 43 317 71 11
Email: investor.relations@ch.abb.com




Permalink : https://www.aetoswire.com/news/abb-covid-19-update-nbsp/en

XPRIZE Responds to COVID-19 by Uniting a Global Alliance of Innovators to Find Unconventional Solutions to Pandemic Threats

XPRIZE launches COVID-19 response platform, in collaboration with Anthem, and calls on the global community to unite, collaborate and share information to address immediate needs and find long-term, durable solutions to pandemic threats



LOS ANGELES -Sunday 29 March 2020 [ AETOS Wire ]

(BUSINESS WIRE)-- XPRIZE, the world’s leader in designing and operating incentive competitions to solve humanity’s grand challenges, reveals the XPRIZE Pandemic Alliance, a global coalition that combines the power of collaboration, competition, shared innovation and radical thinking to accelerate solutions that can be applied to COVID-19 and future pandemics.

The XPRIZE Pandemic Alliance launched to address the immediate needs of the COVID-19 crisis by expanding visibility into solutions underway. This launch comes with an open call to arms to the world’s innovators, clinicians, researchers, data scientists, institutions, and experts to join the Alliance and share existing work and resources using covid19.xprize.org. This website will allow the global community to:

Participate in the latest breakthroughs, research and solutions in development;
Make asks of what they need and allow XPRIZE, the Alliance members and their vast network of supporters and partners to offer their resources to help enable and accelerate innovators to reach their goals faster.
In the immediate term, the Alliance will focus on areas such as accelerating solutions for remote care, provisioning personal protective equipment to the front lines, increasing access to testing, and improving food and medicine security for vulnerable populations, among others.

As part of this Alliance, researchers and scientists are invited to share and access data through the XPRIZE Data Collaborative, a unique platform for researchers and innovators to collaborate, share and learn from data in a broad spectrum of fields in their search for solutions. This trove of data aims to unlock new approaches to fighting pandemics and will serve as the backbone to the collective effort that will prepare us for additional pandemic spikes like COVID-19, or other viral threats.

As part of the XPRIZE Data Collaborative, our launch partner, Anthem, is taking the lead by providing vetted partners with access to one of the largest certified deidentified data set including years of longitudinal data for prior viral outbreaks (e.g., swine flu, avian flu, influenza).

XPRIZE will also host and launch a series of rapid data challenges in support of the Alliance’s initiatives, which may include developing an early warning system for future pandemics, predictive models for public health resource allocation, more efficient and affordable diagnostics, treatments and cures that can be rapidly reproduced, or others based on insights drawn from the collaborators.

Other notable global partners that have already agreed to join the Alliance include United States Department of Veterans Affairs, Ending Pandemics, Intel, Illumina, IEEE Standards Association, MIT Solve, C2 International, Cloudbreak Health, the Foundation Botnar, McGill University, Nvidia, the Patrick J. McGovern Foundation, PPE Coalition, and UCSD. XPRIZE is actively calling for more partners and members to join the Alliance.

“There are few times in recent history when one pandemic has affected so many people, but with all of us focused on one problem, it means impact and solutions will only be accelerated, and we’re excited to work with Anthem to amplify the potential of this platform in quickly enabling global talent to join the fight,” said XPRIZE CEO Anousheh Ansari. “At XPRIZE, we believe radical breakthroughs can come from anyone, anywhere, and our response to COVID-19 will help provide solutions when humanity’s most vulnerable need it most.”

“In this time of crisis, we see an opportunity to come together as a community via the powerful XPRIZE platform to address the most acute needs in the system today and to accelerate new solutions: from protecting our healthcare workers at the front lines and proactively taking care of the high risk populations to developing new approaches to diagnostics, therapy and vaccines,” said Rajeev Ronanki, Chief Digital Officer at Anthem.

“COVID-19 is not the first, nor the last pandemic humanity will face, and future pandemics could be far worse,” said XPRIZE Founder and Executive Chairman Peter H. Diamandis, MD. “For 25 years, XPRIZE has focused on solving global grand challenges, crowdsourcing solutions. The XPRIZE does this by inspiring innovators around the world to use exponential technologies to address problems in unbelievably short timeframes. The XPRIZE Pandemic Alliance will leverage data and human collaboration like never before to facilitate technological breakthroughs for the benefit of humankind.”

For more information, visit covid19.xprize.org.

Additional Quotes from XPRIZE Pandemic Alliance Partners:

“Technology can play a role in helping us to address the world’s largest challenges,” said Stacey Shulman, Chief Innovation Officer and VP, IOT Group, Intel. “Intel is partnering with XPRIZE to enable the larger community to find creative and impactful solutions for this global pandemic.”

“Never before have we had both the technology and collective will to develop a proactive global network for real time assessment and monitoring of infectious epidemics,” said Dr. Phil Febbo, Senior Vice President and Chief Medical Officer, Illumina. “We are pleased to be participating and helping to ensure that laboratories using our sequencers worldwide can integrate into a global community committed to preventing pandemics.”

“In response to the ongoing threat of COVID-19, Solve is focused on finding and supporting innovative solutions that address global health preparedness, early detection, and rapid response,” said Alex Amouyel, Executive Director at MIT Solve. “Better data sharing and analysis is one area that is critical in the effort to slow and track the spread of COVID-19 and future disease outbreaks—and Solve is pleased to join the XPRIZE Global Pandemic Data Alliance in that endeavor.”

"We are finding solutions and new innovations guided by lived experience, empathy, and a love of humanity and coming from unexpected and underexplored sources—makers/tinkerers who are also frontline health workers, student inventors, data scientists driven by social purpose," said Vilas Dhar, Trustee of the Patrick J. McGovern Foundation. "This Alliance creates a platform to engage those actors and many more in a shared quest to alleviate suffering and create a new paradigm for pandemic response."

XPRIZE

XPRIZE designs and operates multi-million-dollar, global competitions to accelerate the development of technological breakthroughs that benefit humanity. Active competitions include the $10 Million ANA Avatar XPRIZE and the $5 Million IBM Watson AI XPRIZE, the $20 Million NRG COSIA Carbon XPRIZE, and the $10 Million Rainforest XPRIZE. For more information, visit xprize.org.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200326005217/en/

Contacts
Katherine Schelbert
XPRIZE
katherine.schelbert@xprize.org

Caden Kinard
XPRIZE
caden.kinard@xprize.org
(949) 280-0182


Permalink : https://www.aetoswire.com/news/xprize-responds-to-covid-19-by-uniting-a-global-alliance-of-innovators-to-find-unconventional-solutions-to-pandemic-threats/en

The Unprecedented Covid-19 Situation and its Impact on TV Advertising

Update brought to you by AMSI – A Choueiri Group Brand


Dubai, United Arab Emirates, -Sunday 29 March 2020 [ AETOS Wire ]

At a time when regional audiences are staying home more than ever before to support lockdown and self-isolation drives, MBC Group (The region’s leading broadcasters) have reported a significant surge in their overall performance, as well as their individual channels.

Insightful data findings from MBC Group indicate that behavioral changes have resulted in greater consumption of premium television content and entertainment. These are being shared to enable advertisers to reinforce and adapt their TV media investments and plans, while encouraging them to uplift their TV advertising initiatives in order to remain top-of-mind and to boost performance as well.

Arabian Media Services International (AMSI) is a part of Choueiri Group and operates as the Exclusive Media Representative for MBC Group.

Arabian Media Services International (AMSI)

As a part of Choueiri Group (The leading Media Representatives in the Middle East), Arabian Media Services International (AMSI) is the official representative of all MBC Group media, which offer leading programs to various social and demographic segments of the Middle East region. The MBC Group has indisputably established itself as the premier provider of TV entertainment content to the Arab World.

Contacts

Choueiri Group

Assad Jamil, +97144545454

ajamil.mr@choueirigroup.com

Permalink : https://www.aetoswire.com/news/the-unprecedented-covid-19-situation-and-its-impact-on-tv-advertising/en

ExThera’s Affinity Blood Filter Is Used to Treat COVID-19 Patients

MARTINEZ, Calif.-Sunday 29 March 2020 [ AETOS Wire ]

(BUSINESS WIRE)-- Treatment of COVID-19 with ExThera’s Seraph®100 Microbind® Affinity Blood Filter (Seraph 100) has begun in hospitals in Germany and Italy. Seraph 100 treatments of COVID-19 are also expected to begin soon in France and the USA.

Seraph 100 is the only ‘hemoperfusion device’ approved for the reduction of pathogens in blood. In recent EU clinical cases improved lung function and rapid reduction of drug-resistant bacterial pathogens occurred with Seraph 100 treatment. Stabilization of blood pressure has also been observed, including during COVID-19 treatment. Another potential benefit of Seraph 100 treatment of COVID-19 is reduction in bloodborne virus/RNA, and the simultaneous treatment of bacterial and fungal ‘secondary infections’.

Clinical results and virus binding studies suggested that Seraph 100 treatment should help in the treatment of COVID-19, and in future epidemics, before vaccines are available. More clinical results are needed to confirm patient benefit in COVID-19, but lab studies with cytokines and other pathogens have accurately predicted Seraph 100 clinical results in other bloodstream infections.

One consideration is whether SARS-CoV-2 is present in the bloodstream of infected patients in measurable concentrations, and if so, at what stage of the infection. Very recent publications and clinician feedback confirm the presence of the virus (RNA) in the blood of critically ill COVID-19 patients. The measured binding capacity of a single Seraph 100 filter (about the size of a 12-ounce soda can) is huge in comparison to the amount of virus present in the bloodstream of critically-ill patients.

Lakhmir S. Chawla, MD, Chair of ExThera’s Scientific Advisory Board added, “In respiratory diseases caused by viruses, the onset of viremia (virus in the bloodstream) typically heralds severe disease. Reducing viral levels of COVID-19 may allow the body’s immune system to combat the deadly pathogen.”

President and CEO of ExThera Medical, Robert Ward NAE stated, “We are very pleased to confirm the feasibility of Seraph 100 treatment of COVID-19. Since Seraph 100 treatments have also consistently produced improved oxygenation/lung function, we believe that this feature together with virus reduction may be a useful combination for treating COVID-19, while simultaneously treating the dangerous secondary infections that can occur in COVID-19 patients.”

Seraph 100 has CE Mark approval in the European Union but is not currently approved by the FDA for use in the United States. ExThera has received clinician interest in individual emergency use of Seraph 100 in the USA and we expect COVID-19 treatments to begin here soon, when they meet the criteria outlined in the FDA Guidance. ExThera will report on ongoing EU COVID-19 cases and related case studies as soon as they are available, while adhering to HIPAA and GDPR requirements for patient confidentiality. Related peer-reviewed publications are in preparation or in press.

“We are excited about adding SARS-CoV-2 to the long list of bloodborne pathogens that Seraph 100 can target,” commented Keith McCrea, PhD. and Chief Science Officer of ExThera Medical. “This can open up a new treatment modality for this and future emerging diseases for which there are few if any treatments.” Seraph 100’s very broad-spectrum capability is based on its large biomimetic blood-contacting surface that imitates the binding sites disease-causing pathogens target once they find their way into the bloodstream.

The Seraph 100 blood filter provides a needed option for treating life-threatening bloodstream infections using new technology. Whereas first-generation hemoperfusion devices remove only molecules, Seraph 100 also quickly lowers the concentration of bacteria, viruses, and fungi in whole blood. Seraph 100 is able to significantly reduce the bloodstream concentration of both drug-susceptible and drug-resistant pathogens, providing a long-awaited adjunctive therapy that addresses the severe problem of drug-resistance, and new and future bacterial, fungal and viral threats like COVID-19.

Professor Jan Kielstein, Director of Medical Clinic V, Academic Teaching Hospital Braunschweig, Germany who has performed many Seraph 100 treatments recently said, "When a pathogen like SARS-CoV-2 comes out of Pandora's Box we have to think outside of the box for a countermeasure. Seraph 100 is a disruptive technology that had been shown to eliminate infectious agents from the blood without side effects. Extracorporeal treatment with the Seraph 100 could offer an added benefit to critically ill patients with severe COVID-19."

Seraph 100 received CE Mark approval for the broad indication of pathogen reduction during bloodstream infections in adjunction with antibiotic therapy. Seraph 100 distributors in the EU include Heinz Meise GmbH in Germany, Burke & Burke in Italy, and TOP Medical in the Benelux countries. Distributors have recently been named in several other regions. Working with Gorta, Ireland’s oldest NGO, ExThera has also entered a public-private partnership designed to strengthen public health systems in developing countries by making world-class medical devices available at affordable prices.

About the Seraph® 100 (Seraph) Microbind® Affinity Blood Filter

As a patient's blood flows through the Seraph filter, it passes over tiny beads with receptors that mimic the receptors on human cells that pathogens target when they invade the body. Harmful substances are quickly captured and adsorbed onto the surface of the beads and are thereby removed from the bloodstream. Seraph does not add anything to the blood, which is returned to the patient with blood cells and proteins intact. Seraph targets the pathogens that cause the infection, while it also binds and removes harmful substances generated by the pathogen and by the body’s response to the infection. Seraph’s adsorption media (the beads) constitute a flexible platform that uses immobilized (chemically bonded) heparin for its well-established blood compatibility and its unique ability to bind bacteria, viruses, fungi, and important sepsis mediators reported to contribute to organ failure during sepsis. The ‘anti-thrombogenic’ heparin media can be combined with other ExThera-proprietary media to tailor the capability of future Seraph products for the treatment of specific diseases, or to further broaden Seraph’s capability.

About ExThera Medical

Based in Martinez, California, near San Francisco, and in Vaals, The Netherlands, ExThera Medical Corporation is a privately held medical device company developing innovative blood filters capable of removing a broad range of harmful substances from the blood. The company develops therapeutic products to treat patients in the hospital or clinic, during epidemics, or on the battlefield. Led by an accomplished management team with decades-long experience in the development and manufacture of blood-contacting implants, devices, and enabling biomaterials technology, the company has strong patent protection and a growing body of data from independent laboratory studies, from its participation in DARPA’s Dialysis-Like Therapeutics program, and from successful clinical use in the EU.

For more information and an instructive video please visit our website: www.extheramedical.com

Seraph 100 is not currently approved for use by the US FDA

Disclaimer: All information contained in this news release derives from plausible reliable sources, which, however, have not been independently examined. There is no warranty, confirmation or guarantee, and no responsibility or liability is taken concerning correctness or completeness. As far as it is allowed by the relevant law, no liability whatsoever is taken on for any direct or indirect loss caused by the deployment of this news release or its contents. This communication includes forward-looking statements regarding events, trends and business prospects that may affect our future operating results and financial position. Such statements are subject to risks and uncertainties that could cause our actual results and financial position to differ materially. The investment and/or the revenues that arise from it can rise or fall. A total loss is possible. Persons who are in possession of this news release are requested to obtain information concerning possible legal limitations and to observe them accordingly. We assume no responsibility to update or revise any forward-looking statements contained in this news release to reflect events, trends, or circumstances after the date of this news release.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200326005174/en/

Contacts
Galit Gelman & Mandy Van Haaren
Media@extheramedical.com




Permalink : https://www.aetoswire.com/news/extherarsquos-affinity-blood-filter-is-used-to-treat-covid-19-patients/en

Jack Ma Foundation and Alibaba Foundation Donate to Seven More Countries in Asia to Fight COVID-19

• Additional medical supplies to be donated to Azerbaijan, Bhutan, India, Kazakhstan, Kyrgyzstan, Uzbekistan and Vietnam

• Total recipient countries in Asia increased to 23



HANGZHOU, China-Sunday 29 March 2020 [ AETOS Wire ]

(BUSINESS WIRE)-- The Jack Ma Foundation and the Alibaba Foundation today announced donations of essential medical supplies to seven more countries, namely Azerbaijan, Bhutan, India, Kazakhstan, Kyrgyzstan, Uzbekistan and Vietnam.

Collectively, these seven countries will receive a total of 1.7 million face masks, 165,000 test kits as well as protective clothing and medical equipment such as ventilators and forehead thermometers. With this announcement, the two Foundations have now donated essential medical supplies to 23 Asian countries totalling 7.4 million masks; 485,000 test kits; 100,000 sets of protective clothing along with other medical equipment.

The first batch of medical supplies for India arrived in Delhi last night and were received by the Indian Red Cross Society. Similar to the arrangement with the Italian Red Cross Society, the Indian charity will facilitate the distribution of these supplies in the country. The donations are expected to reach other countries in the coming days.

Mr. Neel Kamal Singh, Deputy Secretary, Indian Red Cross Society took receipt of the donations from Mr. Vivek Sehgal, Manager, Alibaba Cloud India, acting on behalf of the Jack Ma Foundation and the Alibaba Foundation. Ms. Ma Jia, Deputy Chief of Mission of the Embassy of China in India, was also present to show the embassy’s support towards this humanitarian initiative.

“Government of India has taken extensive steps to manage the COVID-19 situation. To supplement the efforts of government, Indian Red Cross has mobilised first tranche of supplies consisting of facemasks, protective body suits and essential medical equipment. This consignment, which was received yesterday, has been donated by Jack Ma Foundation and Alibaba Foundation. Indian Red Cross appreciates their magnanimity at this difficult juncture,” said Mr. R.K Jain, IAS (Rtd), Secretary General, Indian Red Cross.

“We are one with the global community in the intense battle to protect all families against Covid-19. We are committed to doing everything we can to make a difference, most importantly by sourcing these supplies and overcoming logistical challenges to get the medical supplies to where they are needed as fast as we can,” said the Jack Ma Foundation.

These donations are among a number of aid initiatives from the Alibaba Foundation and Jack Ma Foundation to support the areas of the world affected by the Covid-19 crisis, sourcing and delivering various types of medical supplies to countries across Asia, North America, Latin America, Europe and Africa. The donation by the two foundations to Vietnam is in addition to the recent donation by Lazada Group, Alibaba Group’s local e-commerce business unit in Southeast Asia.

More initiatives and donations may be announced in the coming days and weeks.

The Jack Ma Foundation and the Alibaba Foundation also supported the publication of a handbook with key lessons and experience from doctors, healthcare workers, and hospital administrators at the First Affiliated Hospital, Zhejiang University School of Medicine (FAHZU), who were on the frontline of COVID-19 treatment in China and crucial to slowing its spread. The handbook is available for global medical health professionals at https://covid-19.alibabacloud.com/.

Follow @JackMa and @foundation_ma on Twitter for the latest efforts of Jack Ma Foundation and Alibaba Foundation to support the global fight against COVID-19.

About Jack Ma Foundation

Established by Jack Ma, the founder of Alibaba Group, the Jack Ma Foundation was founded on 15 December 2014 and has been focusing on education, entrepreneurship, women’s leadership, and the environment. The Foundation aspires to be a reliable, participative, and sustainable philanthropic organization. The Jack Ma Foundation has so far supported projects worldwide including the Jack Ma Rural Education Program, the Africa Netpreneur Prize Initiative, the Ma & Morley Scholarship Program, and Jordan's Queen Rania Foundation. Additionally, the Foundation has also funded a number of projects in its priority areas. The Jack Ma Foundation is committed to empowering rural educators, entrepreneurs, rural children, young start-ups, and women to equip them for the future and to help build a happier, healthier, more sustainable and more inclusive society.

About Alibaba Foundation

The Alibaba Foundation, established in December 2011, aims to create a culture that encourages people to get involved in philanthropy, make it sustainable and genuinely contribute to civil society and nature. Its key funding aspects include water protection, environmental awareness promotion and development of green organizations. Alibaba Group is committed to devoting a percentage of its annual income to the Alibaba Foundation to ensure stable long-term funding that will allow for timely response in the event of natural disasters or expansion of philanthropic projects.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200328005024/en/

Contacts

Rico Ngai
Alibaba Group
+852 9725 9600
rico.ngai@alibaba-inc.com

Adam Najberg
Alibaba Group
+852 5474 3262
adam.najberg@alibaba-inc.com


Permalink : https://www.aetoswire.com/news/jack-ma-foundation-and-alibaba-foundation-donate-to-seven-more-countries-in-asia-to-fight-covid-19/en

EasyClocking facilitates for employees to work from home through it's easy attendance and job coding mobile app

Dubai, United Arab Emirates, -Sunday 29 March 2020 [ AETOS Wire ]

Working from home? EasyClocking has just made it easier for all the companies in the MENA region.

EasyClocking®, a leading edge developer of next generation time & attendance and workforce management systems, has announced that it will be offering 2 months free services in the MENA region for its time and attendance mobile application. The app offers employees the ability to manage projects in an easy way by specifying the job activity when clocking in/out from their phone.

A representative from EasyClocking MENA office informed," Today, the world is facing an unprecedented epidemic which has forced many employees to work from home. We are committed to support companies in the MENA to adapt and overcome current challenges. We have recently received a tremendous increase from companies requesting our mobile attendance and job tracking application. These features offer the ability to manage jobs and projects from your home or anywhere around the world, allowing to identify labor costs attributed to projects or jobs by employee, department, and task-type".

The Research & Development team at EasyClocking® is at all times concentrating on improving our existing solutions and innovating new ones. Matched by business-focused, technical support, our response to your objectives has led to the highest levels of customer satisfaction in the industry. At the heart of the company is a team of skilled product developers, programmers and technical support staff. Along with sales, marketing and administration staff, they are committed to providing our customers with an unrivaled expertise, service and support.

Ten years of experience has labeled EasyClocking as a reliable name in the Time & Attendance industry. EasyClocking’s global presence has reached over 30 countries. It is a trusted name in over 50,000 time & attendance systems installed in the world today, to a variety of markets including government agencies, law enforcement, financial services, healthcare, education, commercial enterprises, industrial, construction, hospitality and the retail industry.

Contacts

Faysal ELChamaa
Managing Director
+971563426662
faysal@easyclocking.com


Permalink : https://www.aetoswire.com/news/easyclocking-facilitatesnbspfor-employees-to-work-from-home-throughnbspit39s-easy-attendance-and-job-coding-mobile-app/en

250 Firms Select the Moody’s Analytics CreditLens™ Solution

NEW YORK-Wednesday 25 March 2020 [ AETOS Wire ]

(BUSINESS WIRE)-- Moody’s Analytics, a leading provider of financial intelligence, announced today that more than 250 institutions globally selected the CreditLens credit lifecycle management solution, less than a year after reaching the 100-client threshold.

Built on the latest cloud-based technology, the CreditLens platform helps businesses digitally transform their commercial credit processes to make faster and better-informed decisions. It applies artificial intelligence and machine learning to facilitate process automation and help clients improve efficiency, reduce errors, and streamline workflows.

The solution recently received a SOC 2 attestation report confirming its adherence to the American Institute of Certified Public Accountants’ security and availability controls standards.

In 2019, Professional Bank became one of the first community banks in the US to automate its business loan applications. They accomplished this with the help of the CreditLens platform and other Moody’s Analytics tools. “This investment has enhanced our deal flow management, loan review, and approval processes, directly benefitting our commercial borrowers,” said Professional Bank Chairman and CEO Daniel R. Sheehan. “Our team continues to focus on leveraging technology to improve service and strengthen our credit quality controls as we continue to grow.”

“Evolving market needs require institutions to take a flexible, holistic approach to lending processes,” added Moody’s Analytics Managing Director Elaine Wong. “We are grateful that so many firms have trusted us for their credit management needs. We look forward to working with them—and many others—for a long time to come.”

Click here to learn more about the Moody’s Analytics CreditLens solution.

About Moody’s Analytics

Moody’s Analytics provides financial intelligence and analytical tools to help business leaders make better, faster decisions. Our deep risk expertise, expansive information resources, and innovative application of technology help our clients confidently navigate an evolving marketplace. We are known for our industry-leading and award-winning solutions, made up of research, data, software, and professional services, assembled to deliver a seamless customer experience. We create confidence in thousands of organizations worldwide, with our commitment to excellence, open mindset approach, and focus on meeting customer needs. For more information about Moody’s Analytics, visit our website or connect with us on Twitter and LinkedIn.

Moody's Analytics, Inc. is a subsidiary of Moody's Corporation (NYSE: MCO). Moody’s Corporation reported revenue of $4.8 billion in 2019, employs approximately 11,100 people worldwide and maintains a presence in 40 countries.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200219005683/en/

Contacts

KATERINA SOUMILOVA
Moody’s Analytics Communications
001.212.553.1177

Moody’s Analytics Media Relations

moodysanalytics.com
twitter.com/moodysanalytics
linkedin.com/company/moodysanalytics


Permalink : https://www.aetoswire.com/news/250-firms-select-the-moodyrsquos-analytics-creditlenstrade-solution/en

DXC Technology’s Integrated Patient-Centered Care Solution Creates New Opportunities for Interoperability and Patient Engagement

TYSONS, Va-Sunday 29 March 2020 [ AETOS Wire ]

(BUSINESS WIRE)-- DXC Technology (NYSE: DXC) today introduced an advanced Patient-Centered Care solution, a customizable and personalized-health offering that gives healthcare providers the technology to meet the high expectations of today’s patients — without sacrificing cost containment and clinician satisfaction.

The healthcare industry is experiencing a value-based shift of epic proportions, driven by key external trends like an aging population; the proliferation of chronic diseases; rising healthcare costs; staffing shortages; and digital citizenship creating more informed patients. To elevate the patient experience, improve individual outcomes and create a healthier population, healthcare leaders are seeking new business and integrated care models that merge healthcare and life sciences while empowering patients and providers alike.

To help solve these challenges, DXC Patient-Centered Care provides advanced patient-engagement tools that offer convenient care from anywhere, via phone or tablet, at an affordable price. Backed by DXC’s interoperability, analytics and security products, the solution enables providers to access a continuous stream of patient-care data, helping them put the patient first throughout the continuum of care.

“In the age of ‘Dr. Google’ and same-day Amazon deliveries, patients are increasingly more demanding. They will no longer tolerate half-day waits for discharge instructions that could be delivered in seconds via a chatbot, or receive test results by snail mail when they could be viewed immediately on a mobile app. They expect better value and engagement from caregivers, driving the industry to move from traditional care-delivery models toward a patient-centered journey of care,” said Andrea Fiumicelli, vice president and general manager, Healthcare and Life Sciences, DXC Technology. “Our new Patient-Centered Care solution combines DXC’s industry expertise and leading healthcare technology to equip providers with custom-built, next-generation and coordinated care solutions.”

“The future of connected healthcare is centered around collaboration and care, and today’s busy providers need to find innovative ways to connect with their patients within and beyond the walls of a hospital or clinic,” said Dr. Michael Dahlweid, who recently joined DXC as its new global chief medical officer. “Our goal is to enable care teams to share health information across multiple systems, channels, practices and infrastructures, and aggregate it into a secure, consolidated view of the patient’s history of care. This persona-based access to real-time health data will allow clinicians to make the best possible decisions for their patients’ treatment. With speed, scale, flexibility and continuous innovation, DXC Technology prepares traditional healthcare organizations to become major digital-health enablers.”

The DXC Healthcare Portfolio

Patient-Centered Care is the newest solution in DXC’s extensive healthcare portfolio that is transforming the healthcare industry. The portfolio also includes:

• DXC Open Health Connect, a healthcare platform that helps improve healthcare outcomes by creating a connected ecosystem for patients, providers and payers.
• DXC Healthcare Cloud, a cloud-based solution that reduces complexity and risk while allowing approved parties to securely access applications and data 24/7.
• DXC Healthcare Security Services — for which DXC was recently named a leader in the Everest Group PEAK Matrix Assessment 2020 — to help healthcare providers quickly identify and respond to threats, protect data and patient privacy, and securely manage patient identities stored on-premise or in the cloud.
• DXC Health360™, a cloud-based solution that enables providers and payers to personalize care experiences, deliver quality and increase customer loyalty at a lower cost.
• DXC Life Sciences solutions, which give life sciences organizations — including all 12 U.S. Fortune 500 pharmaceutical companies — the tools they need to accelerate innovation, improve operational efficiencies and reduce time to market for new therapies, devices and medicines.

About DXC Technology

DXC Technology (NYSE: DXC) helps global companies run their mission critical systems and operations while modernizing IT, optimizing data architectures, and ensuring security and scalability across public, private and hybrid clouds. With decades of driving innovation, the world’s largest companies trust DXC to deploy our enterprise technology stack to deliver new levels of performance, competitiveness and customer experiences. Learn more about the DXC story and our focus on people, customers and operational execution at www.dxc.technology.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200318005372/en/

Contacts

Jim Pasinski, Corporate Communications, +1.716.307.5454, james.pasinski@dxc.com
Shailesh Murali, M&A and Investor Relations, +1.703.245.9700, smurali30@dxc.com


Permalink : https://www.aetoswire.com/news/dxc-technologyrsquos-integrated-patient-centered-care-solution-creates-new-opportunities-for-interoperability-and-patient-engagement/en

From USA to France and From UK to Mexico, Bacardi Diverts Global Production to Increase Hand Sanitizer Supply for Local Communities

Brands across company’s portfolio including BACARDÍ®, MARTINI®, GREY GOOSE®, BOMBAY SAPPHIRE®, DEWAR’S® and ANGEL’S ENVY® unite to help produce more than 267,000 gallons (1.1 million liters) of hand sanitizers.

HAMILTON, Bermuda-Sunday 29 March 2020 [ AETOS Wire ]

(BUSINESS WIRE)-- Family-owned Bacardi has expanded its commitment across countries and brands to help produce more than 267,000 gallons (1.1 million liters) of hand sanitizers, as worldwide demand continues to exceed supply in efforts to reduce the risk of COVID-19. This week, eight Bacardi-owned manufacturing sites across the United States, Mexico, France, England, Italy and Scotland are joining the efforts, following last week’s announcement that Bacardi in Puerto Rico would supply alcohol to make hand sanitizers. Across the sites, Bacardi is diverting its global production power, resources and processes to supply the much-needed alcohol essential for the increased production of hand sanitizers.

Bacardi is also playing a part in donating these products to local organizations and emergency responders, as well as its employees and contractors. In addition, the company is providing alcohol at cost to select partner companies looking to ramp up their production of hand sanitizers for commercial sale. These temporary, emergency actions at all locations will not disrupt the supply of brands in the Bacardi portfolio.

“Over our 158-year history, we have risen to many challenges and we are doing the same again in response to COVID-19,” said Jean-Marc Lambert, SVP Global Operations for Bacardi. “All our brands and partners involved in this initiative will help people most in need benefit from the supply of these hand sanitizers. Our goal is to make a very real difference in the fight against COVID-19.”

The current list of sites providing support either immediately or in the coming week are:

BACARDÍ rum in Puerto Rico – partnered with Puerto Rico based manufacturer Olein Refinery to provide raw materials that will enable the production of more than 1.7M units of 10-ounce (300 ml) hand sanitizers. Donated product to local USPS, firefighters, police and non-profit Somos Unidos (United Way);
Bacardi Bottling Corporation in Jacksonville, FL, USA – is planning to help produce approximately 23,000 gallons (87,000 liters) to make 120,000 units of 25-ounce (750 ml) bottles hand sanitizer for donation to local hospitals, firefighters and police. In addition, the team will supply 7,600 gallons (29,000 liters) to nearby manufacturers.
BACARDÍ rum in Tultitlán, Mexico – supplying more than 5,200 gallons (20,000 liters) of alcohol to nearby manufacturer, Grupo Sterk, to help increase production of hand sanitizer by approximately 6,300 gallons (24,000 liters), of which 2,100 gallons (8,000 liters) will be donated by Bacardi to local communities in Tultitlán, Arandas and Atotonilco;
GREY GOOSE® vodka in Cognac, France – will supply 7,600 gallons (29,000 liters) of alcohol per day to French companies to increase supply of hand sanitizers by 9,500 gallons (36,000 liters) for local pharmacies, hospitals and the emergency services;
BOMBAY SAPPHIRE® gin in Hampshire, England – is helping to produce a small quantity of hand sanitizers that will be donated to local doctors, chemists and care homes;
MARTINI in Pessione, Italy – is supplying alcohol for the production of 1,000 7-ounce (200ml) hand sanitizers for the local community, Red Cross and local emergency services;
DEWAR’S® Blended Scotch Whisky in Aberfeldy, Scotland – is helping to produce a small quantity of hand sanitizers for the Scottish Ambulance Association among other local community groups;
ANGEL’S ENVY® Kentucky Straight Bourbon in Louisville, KY, USA – is supplying nearly 1,000 gallons (3,800 liters) of alcohol to create approximately 16,000 8-ounce (250 ml) bottles of free hand sanitizers for first responders and healthcare professionals.
All hand sanitizers produced in collaboration with Bacardi contain more than the minimum alcohol content recommended by the World Health Organization for containing the spread of the virus.

About Bacardi

The Bacardi Limited brand portfolio comprises more than 200 brands and labels, including BACARDÍ® rum, GREY GOOSE® vodka, PATRÓN® tequila, DEWAR’S® Blended Scotch whisky, BOMBAY SAPPHIRE® gin, MARTINI® vermouth and sparkling wines, CAZADORES® 100% blue agave tequila, and other leading and emerging brands including WILLIAM LAWSON’S® Scotch whisky, ST-GERMAIN® elderflower liqueur, and ERISTOFF® vodka. Founded more than 158 years ago in Santiago de Cuba, family-owned Bacardi Limited currently employs more than 7,000, operates production facilities in 11 countries, and sells its brands in more than 170 countries. Bacardi Limited refers to the Bacardi group of companies, including Bacardi International Limited. Visit www.bacardilimited.com or follow us on Twitter, LinkedIn or Instagram.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200325005615/en/



Contacts
Jessica Merz, Director Global Corporate Communications, jmerz@bacardi.com
Andrew Carney, Director Global Corporate Communications, acarney@bacardi.com

Permalink : https://www.aetoswire.com/news/from-usa-to-france-and-from-uk-to-mexico-bacardi-diverts-global-production-to-increase-hand-sanitizer-supply-for-local-communities/en

Moody’s Provides $1 Million in Funding for COVID-19 Relief

NEW YORK-Sunday 29 March 2020 [ AETOS Wire ]

(BUSINESS WIRE)-- Moody’s Corporation (NYSE: MCO) today announced that it will fund a $1 million program of charitable donations and other support to help address the immediate and long-term impact of COVID-19. Moody’s will extend support to its existing philanthropic partners to help small businesses and education systems and reconfigure its employee volunteer programs to assist communities most affected by the pandemic.

“COVID-19 has caused unprecedented disruption to the health and economic security of people around the world,” said Raymond McDaniel, President and CEO of Moody’s Corporation. “Moody’s Corporation and our employees are committed to assisting organizations that are providing vital relief and recovery work in local communities during this difficult time.”

To help with urgent needs, Moody’s will provide $550,000 of funding for humanitarian aid to support global efforts to alleviate food insecurity, bolster healthcare systems, purchase medical supplies, and support research focused on containment and treatment. Funds will also be distributed to organizations involved in direct relief work in communities where Moody’s operates, including:

Global: UN Foundation’s COVID-19 Solidarity Response Fund supporting the World Health Organization (WHO) and its partners
North America: Team Rubicon US/Canada and NYC COVID-19 Response & Impact Fund
Latin America: Direct Relief International
EMEA: Doctors Without Borders and Save the Children
APAC: Give2Asia
This funding builds on Moody’s $50,000 donation to Give2Asia in January, which helped provide health care workers with training and medical equipment to contain the spread of COVID-19 in China.

Moody’s will also increase support for its existing CSR program partners by pledging an additional $450,000 in unrestricted grants to address the impact of COVID-19 on small businesses and education systems. The company will also provide partners with pro bono resources to bolster their operations and support their transition to virtual programs.

In addition, Moody’s will be instituting a virtual employee volunteer program and reconfiguring its Moody’s Future Solutions™ program to allow employees to continue their community engagements while adhering to social distancing guidelines. The company also will match eligible employee donations to nonprofits responding to COVID-19 via its Matching Gifts Program.

ABOUT MOODY’S CORPORATION

Moody’s (NYSE:MCO) is a global integrated risk assessment firm that empowers organizations to make better decisions. Our data, analytical solutions and insights help decision-makers identify opportunities and manage the risks of doing business with others. We believe that greater transparency, more informed decisions, and fair access to information open the door to shared progress. With over 11,000 employees in more than 40 countries, Moody’s combines international presence with local expertise and over a century of experience in financial markets. Learn more at moodys.com/about.

Moody’s builds toward a world where more people have access to opportunity, and where everyone has what they need to grow and thrive. We are committed to opening the door to brighter futures through our global corporate social responsibility programs connecting people around the world with the knowledge and resources they need to succeed. For more information visit moodys.com/csr.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200326005179/en/

Contacts
SHIVANI KAK
Investor Relations
212.553.0298
shivani.kak@moodys.com

JORDAN BRUECKNER
Communications
+1 212-553-7931
jordan.brueckner@moodys.com


Permalink : https://www.aetoswire.com/news/moodyrsquos-provides-1-million-in-funding-for-covid-19-relief/en

amnimo Inc. Starts Development of High-performance, Robust LTE Gateway (Edge Gateway) for Industrial Use

TOKYO -Friday 27 March 2020 [ AETOS Wire ]

(BUSINESS WIRE)-- amnimo Inc. (Headquarters: Musashino City, Tokyo; President & CEO: Koichi [Casey] Taniguchi; hereafter, “amnimo”) starts developing an industrial-use LTE gateway, “Edge Gateway,” which is equipped with rich computing resources and a high level of robustness.

IoT is a mechanism by which a variety of devices are connected to each other via the network or the cloud service; these devices exchange information with each other. Recently, numerous approaches to the use of industrial-use IoT (IIoT) have been evolving in all types of industries. As IIoT continues to proliferate, examples of user work process improvements are increasing, but at the same time, we are witnessing operational issues such as suppressing failures in harsh external environments and being able to remotely deal with failures without going to the site. There have also been requests to process large volumes of data, such as video, using Edge in an advanced manner.

To resolve such issues, amnimo is developing the “Edge Gateway,” which is optimized for IIoT. The objective is to equip the Edge Gateway with LTE communication features that can be used in a wide variety of industries; in particular, to develop an optimal design for use in surveillance-camera systems.

[Characteristics of the Edge Gateway]

    Wide operating temperature range and power voltage range. Equipped with power circuits that are robust against noise and sudden outages, it has features for automatic recovery in case of a failure. This helps achieve stable operation even in harsh outdoor environments.
    Equipped with 2 GB of RAM and 32 GB eMMC for program storage space as the standard configuration, it can also be operated using a 2-TB SSD (Solid State Drive), enabling large-volume video data to be stored within the Edge Gateway.
    Equipped with a power-supply function for PoE(*1) compatible devices, it can be directly connected to a maximum of four IP cameras without using a PoE hub.
    The communication modules can accommodate two types of plastic SIM cards and eSIMs for a maximum of four different carrier SIMs, enabling the user to bypass communication failures by switching SIMs at high speeds in cases of emergency.
    Customer app development is possible on the Ubuntu OS; in addition, software development kits are provided for partners.
    Equipped with a VMS (Video Management System (*2)) as standard, simplifying the process of constructing small-, medium-, and large-scale surveillance systems.
    An extension port slot is internally provided in the Edge Gateway, enabling smooth addition of future functional extensions.

*1 Power over Ethernet: Specification wherein power is provided to the connected device(s) using Ethernet communication cables.
*2 System for saving and managing video captured using a surveillance camera.

In addition, we are developing a “device management system” to resolve issues related to operation on IIoT devices, such as the Edge Gateway. This device management system is a cloud service that enables initial configuration of IIoT devices, remote configuration and firmware updates, management of installation location, equipment life monitoring, log collection during operation, problem analysis and replacement, and transfer of configuration data for troubleshooting, thereby reducing the burden on the operator.

amnimo provides customer support for IIoT service and surveillance-camera systems, with the following objectives: “fast response and resolution for customer issues,” “value creation and innovation,” and “aim to grow with partners.”

About amnimo

amnimo was formed as a solely owned subsidiary of Yokogawa Electric Corporation as a new business to provide Industrial Internet of Things (IIoT) services in May 2018. With an excellent mobility, amnimo makes a swift decision and develops its business in a rapidly changing market. amnimo strengthens collaboration with customers and partner companies in various fields and countries to create new shared values by leveraging IIoT technologies.

To learn more, please visit https://a

mnimo.com/en/

The company names, organization names, and product names used in the document are registered trademarks or trademarks of the relevant organizations.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200322005056/en/

Contacts

amnimo Inc.
Representatives:
Yoshihiro Suzuki​
Yuka Ichikawa​
TEL: +81-422-52-6779
E-mail: info@amnimo.com
URL: https://amnimo.com/en